Jim Cramer Weighs In On Berkshire Hathaway, Range Resources, Zynerba And More
Cramer says although it's speculative, he is bullish on gene sequencing stock Guardant Health Inc (NASDAQ:GH).
He remains bullish on Berkshire Hathaway Inc. Class B (NYSE: BRK-B) and has been recommending the stock since the show began.
Seattle Genetics, Inc. (NASDAQ:SGEN) is a buy, says Cramer.
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.